English
中文
русск
français
español
العربية
It takes around min to read this article.
AstraZeneca's COVID-19 vaccine is 79 percent effective in preventing the disease and does not increase the risk of blood clots, the biotech firm said Monday, following its U.S. Phase III efficiency trials.
The shot was also 80 percent effective for over 65s, it said. Several countries have advised against administering the jab to older people due to a lack of data among elderly participants in previous trials.
Original Text (This is the original text for your reference.)
AstraZeneca's COVID-19 vaccine is 79 percent effective in preventing the disease and does not increase the risk of blood clots, the biotech firm said Monday, following its U.S. Phase III efficiency trials.
The shot was also 80 percent effective for over 65s, it said. Several countries have advised against administering the jab to older people due to a lack of data among elderly participants in previous trials.
Select your report category*
Reason*
Your level privilege is in sufficient. You can go to the “User Center” to view your level information and perform points tasks to upgrade your level.
New sign-in location：
Last sign-in location：
Last sign-in date：
About to jump to an external site.
Security unknown, whether to continue
User Center
My Training Class
Feedback
Report
Share
Comments
Something to say?
Log in or Sign up for free